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13Background: Although potential links between malaria
parasitaemia and hypertension have been hypothesized,
there is paucity of epidemiologic evidence on this link. We
investigated in a population-based survey, the association
between malaria parasitaemia and hypertension in Ivorian
adults.
Methods: We estimated the adjusted odds ratios (OR) and
95% confidence intervals (CI) of hypertension in relation to
malaria parasitaemia using multinomial regression, in 997
randomly selected adults in the ‘Coˆte d’Ivoire Dual Burden
of Disease Study’ (CoDuBu), in south-central Coˆte d’Ivoire.
We defined malaria parasitaemia as a positive rapid
diagnostic test or identification of Plasmodium spp. on
microscopy. Using the mean of the last two of three blood
pressure (BP) measurements and questionnaire data, we
defined hypertension as SBP at least 140mmHg or DBP at
least 90mmHg or clinician-diagnosed hypertension.
Results: Prevalence of malaria parasitaemia and
hypertension were 10 and 22%, respectively. Malaria
parasitaemia was negatively associated with hypertension
in participants with body temperature 36.5 8C or less [OR
0.23 (95% CI 0.06–0.84)]. Contrastingly, microscopic
malaria parasitaemia showed positive associations with
hypertension in participants with elevated body
temperature [>36.5 8C; OR: 2.93 (95% CI 0.94–9.14)].
Participants having microscopic malaria parasitaemia with
elevated body temperature had three-fold higher odds of
hypertension [OR: 3.37 (95% CI 1.12–10.0)] than malaria
parasitaemia-negatives with lower body temperature.
Conclusion: Malaria parasitaemia and hypertension are
prevalent and seemingly linked comorbidities in African
settings. This link may depend on malaria parasitaemia
symptomaticity/latency where individuals with more latent/
asymptomatic malaria parasitaemia have lower risk of
hypertension and those with more acute/symptomatic
malaria parasitaemia have a tendency toward higher BP. The
cross-sectional nature of the study limited the distinction of
short-term BP elevation (interim pathophysiological stress)
from hypertension development. Future longitudinal studies
considering malaria/hypertension phenotypes and host
molecular variations are needed to clarify involved biological
mechanisms, toward comorbidity management.84 www.jhypertension.comKeywords: blood pressure, Coˆte d’Ivoire, hypertension,
infectious disease, malaria, Plasmodium spp
Abbreviations: ACE, angiotensin-converting enzyme; CI,
confidence interval; CoDuBu, Coˆte d’Ivoire Dual Burden of
Disease Study; CR1, chemokine receptor 1; CVD,
cardiovascular disease; Hb, haemoglobin; HDSS, health and
demographic surveillance system; HRP2, histidine-rich
protein 2; LMICs, low-income and middle-income
countries; NCD, noncommunicable disease; OR, odds ratio;
pLDH, parasite lactate dehydrogenase; RDT, rapid
diagnostic testINTRODUCTIONT
he prevalence of hypertension in low-income and
middle-income countries (LMICs) is increasing [1,2],
contributing to higher mortality rates because of
cardiovascular diseases (CVD) [3]. Although this may be
attributed to urbanization and westernization of lifestyle,
they do not explain the high rates that have also been
observed in rural areas [4]. Persons of African ethnic back-
ground are well known to have comparatively higher blood
pressure (BP) and stroke risk than Caucasians [5]. At the
same time, malaria parasitaemia remains prevalent and a
significant contributor to mortality in LMICs [6]. Together
with malaria parasitaemia, hypertension contributes to a
state of double disease burden, which further strains indi-
vidual health and poor health systems in LMICs.DOI:10.1097/HJH.0000000000002071
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Malaria parasitaemia and hypertensionA potential link between malaria parasitaemia and hyper-
tension was hypothesized. Suggested pathways can be
divided into causativemalaria parasitaemia effects and shared
origins [7,8]. Proposed direct effects of malaria parasitaemia
include thepromotion, in the long-term, of an atherosclerosis-
promoting pro-inflammatory state because of repeated infec-
tions [7,9–11]. In-utero and early life effects of malaria para-
sitaemia on low birth weight, malnutrition and stunting, are
established risk factors for CVD later in life [7,12–16]. In
pregnantwomen,malariaparasitaemiaeffectonpreeclampsia
puts themat risk forhypertension [7]. In the short-term,malaria
parasitaemia could induce BP fluctuations in either direction
[11,17]. It is even conceivable that BPmay first increase during
the milder stages of malaria parasitaemia and subsequently
falls as observed in severe malaria [18,19].
The shared origin hypothesis [7,8] is rooted in pathways
common to malaria parasitaemia and hypertension, such as
immunity, inflammation and body fluid regulation, and in
the observation of higher rates of hypertension among
individuals of African and Asian ancestry in malaria-free
western settings [20]. It suggests selective pressure of
genetic variants that protect against malaria or its patho-
genesis, regardless of other potentially resulting negative
systemic outcomes [8,21]. Malaria parasitaemia exerted the
strongest selective pressure on the human genome in recent
history, in part related to sickle cell trait [22]. But the latter
was not related to 24-h BP measurements and arterial
stiffness in African children from a malaria-free region
[23]. Additional genes under selective pressure include
those involved in oxidative stress, inflammation, immunity
and endothelial function [22]. Genetic variants that promote
angiotensin-converting enzyme (ACE) activity, and hyper-
tension [24,25], have higher expression rates in African
Americans compared with whites [26,27], and were associ-
ated with milder forms of malaria [28–30].
However, there is a paucity of population-based epide-
miologic evidence on the association between malaria
parasitaemia and hypertension. Malaria patients had lower
SBP [31], and higher serum ACE activity [29] compared with
controls in hospital-based studies. We investigated using a
population-based approach, the association between
malaria parasitaemia and hypertension in Ivorian adults
from a malaria-endemic setting [32,33].
METHODS
Study population
This study was done within the Coˆte d’Ivoire Dual Burden
of Disease Study (CoDuBu), which aims to investigate the
co-occurrence of infectious diseases and noncommunica-
ble diseases (NCDs), in the Taabo health and demographic
surveillance system (HDSS) [34]. Details of CoDuBu have
been described elsewhere [35]. Briefly, 1019 adults (50%
men) were randomly recruited in 2017 from three Taabo
HDSS communities (Amani-Me´nou, Taabo-Cite´ and Toko-
hiri). Participants, in a fasting state, underwent health
examinations, including anthropometry, BP, haemoglobin
(Hb), malaria rapid diagnostic test (RDT), and thick and thin
blood film microscopy. A biobank constituting blood, stool
and urine was set up for future research on the molecular
basis of infectious disease–NCD relationship. ParticipantsJournal of Hypertensionalso had detailed interviews covering their health status and
lifestyle characteristics.
The CoDuBu study protocol was approved by the Coˆte
d’Ivoire National Research Ethics Committee (ref. 032/
IMSHP/CNER-kp; 24 March 2017) and the Ethics Committee
of Northwest and Central Switzerland (ref. 2016–00143; 2
May 2016). All participants provided written informed
consent before participating in the study, and consented
to be re-contacted for a potential follow-up study.
Case definition of malaria parasitaemia
Venous blood from participants was applied toward RDT and
microscopy for the identification of Plasmodium infection.
RDTwasdoneusingMalariaDual PF/PANAntigen (Histidine-
rich protein II (HRP2)/parasite lactate dehydrogenase
(pLDH)) test (ICT Diagnostics, Cape Town, South Africa),
which is an in-vitro immunochromatographic assay for the
qualitative detection of Plasmodium falciparum, Plasmo-
dium vivax, Plasmodium ovale and Plasmodium malariae
antigens in blood. RDTs were performed by experienced
laboratory technicians, and only valid tests were recorded.
Thick and thin blood films were also prepared, air-dried,
Giemsa-stained, and examined under a light microscope at
high magnification, for Plasmodium spp. identification and
quantification. Parasites were counted against 200 leuko-
cytes (or 500 leukocytes if parasite count was less than 10),
assuming a standard count of 8000 leukocytes/ml of blood
[36]. For quality control, a random sample of 10% of the
slides was re-read by a senior laboratory technician and
inter-rater agreement was 100%.
We identified participants as malaria parasitaemia-posi-
tive, if they tested positive to either RDT or microscopy,
regardless of Plasmodium spp. or density. As the RDT may
detect low-density infections, and the HRP2 antigens of
P. falciparum for a few weeks following parasite clearance
[37], we defined two diagnosis-specific malaria parasitae-
mia, including RDT-only malaria parasitaemia (excluding
those identified by microscopic malaria parasitaemia, rep-
resenting more latent infection) and microscopic malaria
parasitaemia (excluding RDT-only malaria parasitaemia,
representing more active infection).
Case definition of prehypertension and
hypertension
Participants had three BP measurements, 3min apart, using
Omron Oscillograph and appropriate-sized cuffs (OMRON
Healthcare, Kyoto, Japan). The mean of the last two meas-
urements was taken for further analyses. Prehypertension
was defined as mean SBP of 120–139mmHg or DBP of 80–
89mmHg, in the absence of clinician-diagnosed hyperten-
sion. Hypertension was defined as having mean SBP at least
140mmHg or DBP at least 90mmHg or clinician-diagnosed
hypertension or antihypertensive medication use. All cases
of hypertension underwent electrocardiography, had 1
month of free treatment, and were subsequently enrolled
in a subsidized treatment and follow-up plan.Measurement of potential confounders/modifiers
The following variables, which were measured using a
questionnaire, were selected as covariates: age (years;www.jhypertension.com 1385
Eze et al.continuous), sex (male/female), educational attainment
(none/primary/secondary/tertiary), household wealth
index derived as a principal component analysis of prop-
erties belonging to household of the participant [34] and
study area.We further considered CVD risk factors including
smoking status (never/former/current), intake of fruits and
vegetables (never/monthly/weekly/several days per week),
sedentariness (hours per week spent sitting or lying exclud-
ing sleep; continuous), family history of hypertension (yes/
no) and general susceptibility to illness (in comparison to
same sex and age group; lower/higher). Participants also
reported fever (yes/no) before examination.
Weight (kg), height (m) and waist circumference (cm)
were measured and BMI was calculated as the weight–
height-squared ratio (kg/m2). Body temperature was mea-
sured using Omron auricular thermometer (Omron Health-
care, Kyoto, Japan) and was classified along the mean
(36.5 8C/>36.5 8C; range: 34.6–37.9 8C) for analyses. Hb
was measured with HemoCue Hb 301 (HemoCue AB,
A¨ngelholm, Sweden), and anaemia was defined based
on WHO recommendations [38].
Statistical analyses
We described the characteristics of participants using fre-
quencies for categorical variables and means and SDs for
continuous variables. We imputed age-adjusted, sex-
adjusted, and area-adjusted mean of the missing covariate
data. We stratified these characteristics by hypertension
status and tested differences in proportions and means
using x2 and t-tests, respectively.
We performed multinomial logistic regression for asso-
ciations betweenmalaria parasitaemia and prehypertension
and hypertension, in unadjusted and adjusted models. We
performed covariate adjustment in a stepwise fashion and
the covariates included age, sex, educational attainment,
wealth index, area, family history of hypertension, smok-
ing, intake of fruits and vegetables, BMI, waist circumfer-
ence, sedentariness and anaemia. We performed sensitivity
analyses by limiting malaria parasitaemia cases to (sensitiv-
ity model i) RDT malaria parasitaemia (regardless of
microscopy); (sensitivity model ii) microscopic malaria
parasitaemia (regardless of RDT); (sensitivity model iii)
RDT-only malaria parasitaemia (excluding microscopy-
positive cases) and (sensitivity model iv) microscopic
malaria parasitaemia (excluding RDT-only positive cases).
Using the adjusted model, we tested effect modification
by age, sex, self-reported fever, body temperature, family
history of hypertension, and illness susceptibility. We also
performed these effect modification analyses using the
sensitivity models (iii) and (iv) mentioned above. Further-
more, we tested associations of prehypertension and hyper-
tension (and of SBP and DBP) with combinations of
elevated temperature and malaria parasitaemia diagnosis,
in adjusted models. For these analyses, we classified par-
ticipants into six exclusive groups, including (group i)
malaria parasitaemia-negative without elevated body tem-
perature (i.e. no self-reported fever and body temperature
36.5 8 C; reference group); (group ii) malaria parasitae-
mia-negative with elevated body temperature (i.e. self-
reported fever or body temperature >36.5 8C); (group iii)
RDT-only malaria parasitaemia-positive, without elevated1386 www.jhypertension.combody temperature; (group iv) RDT-only malaria parasitae-
mia-positive, with elevated body temperature; (group v)
microscopic malaria parasitaemia-positive, without ele-
vated body temperature and (group vi) microscopic malaria
parasitaemia-positive, with elevated body temperature.
All results are reported as odds ratios (ORs) or beta
coefficients (b) and their 95% confidence intervals (CIs).
All analyses were performed with Stata version 14 (Stata
Corporation, College Station, Texas, USA) and R Studio
version 0.99.092 (R Foundation, Vienna, Austria).
RESULTS
We included 997 (98% inclusion rate) participants for
analyses. Among the excluded were two participants
who lacked BP data, and 20 pregnant women. Included
participants were 51% men, aged 18–87 years, with 55%
having at least primary education. Mean (standard devia-
tion; SD) of SBP and DBP were 122 (18) mmHg and 79 (12)
mmHg, respectively. Compared with nonhypertensive par-
ticipants, hypertensive participants were older, more often
women, had higher socioeconomic status, sedentariness,
adiposity and family history of hypertension (Table 1).
Prevalence of malaria parasitaemia was 10%. Prevalence
of RDT-positive malaria parasitaemia was 9.6%, whereas
microscopic malaria parasitaemia was 5.4%. Most (82%) of
the malaria parasitaemia cases identified by microscopy or
RDT were P. falciparum. Prevalence of self-reported fever
was 14%. Agreement between body temperature and self-
reported fever was 56.3%. Prevalence of prehypertension
and hypertension was 33 and 22%, respectively. Prevalence
of hypertension was higher among malaria parasitaemia-
negative participants (24%) than malaria parasitaemia-pos-
itive participants (14%) but prehypertension was not differ-
ent by malaria parasitaemia status (both 33%).
Associations between malaria parasitaemia and prehy-
pertension and hypertension were generally negative.
Unadjusted ORs of prehypertension and hypertension in
relation to malaria parasitaemia were 0.81 (95% CI 0.51–
1.29) and 0.48 (95% CI 0.26–0.89). Adjusting for age, sex
and socioeconomic covariates attenuated the ORs of pre-
hypertension and hypertension. Associations remained sta-
ble to further adjustment for family history of hypertension,
smoking and nutritional factors, but were further attenuated
on accounting for adiposity and sedentariness. Associations
remained stable to further adjustment for anaemia. Thus,
the fully adjusted ORs of prehypertension and hypertension
in relation to malaria parasitaemia were 0.97 (95% CI 0.59–
1.58) and 0.65 (95% CI 0.32–1.33), respectively (Table 2).
Estimates of association betweenmalaria parasitaemia and
prehypertension and hypertension were robust to sensitivity
analyses, especially when limiting malaria parasitaemia to
RDT, with associations between RDT-only malaria parasitae-
mia and hypertension reaching borderline significance [OR
0.40 (95% CI 0.14–1.14). Associations between microscopic
malaria parasitaemia and prehypertension and hypertension
tended to be positive, with respective ORs of 1.09 (95% CI
0.57–2.11) and 1.05 (95% CI 0.41–2.67) (Table 2).
We observed differences by self-reported fever
(Pinteraction¼ 0.04) and body temperature (Pinteraction¼ 0.04)
0.04) on the association between malaria parasitaemia andVolume 37  Number 7  July 2019
TABLE 1. Summary of participant characteristics
All No hypertension Hypertension P value
Categorical variables N (%) N (%) N (%) x2
All 997 (100) 771 (77.3) 226 (22.7)
Sex
Female 485 (48.7) 361 (46.8) 124 (54.9) 0.033
Male 512 (51.3) 410 (53.2) 102 (45.1)
Formal education
None 448 (44.9) 334 (43.2) 114 (50.4) 0.031
Primary 237 (23.8) 199 (25.8) 38 (16.8)
Secondary 235 (23.6) 182 (23.6) 53 (23.5)
Tertiary 77 (7.7) 56 (7.3) 21 (9.3)
Wealth index tertiles
T1 337 (33.8) 279 (36.2) 58 (25.7) 0.002
T2 330 (33.1) 257 (33.3) 73 (32.3)
T3 330 (33.1) 235 (30.5) 95 (42.0)
Smoking
Never smokers 827 (83.0) 630 (81.7) 197 (87.2) 0.026
Former smokers 81 (8.1) 62 (8.0) 19 (8.4)
Current smokers 89 (8.9) 79 (10.3) 10 (4.4)
Fruit intake
Never 5 (0.5) 3 (0.4) 2 (0.9) 0.015
Monthly 271 (27.2) 193 (25.0) 78 (34.5)
Weekly 630 (63.2) 498 (64.6) 132 (58.4)
Several days/week 91 (9.1) 77 (10.0) 14 (6.2)
Vegetable intake
Never 130 (13.0) 104 (13.5) 26 (11.5) 0.494
Monthly 267 (26.8) 205 (26.6) 62 (27.4)
Weekly 460 (46.2) 360 (46.7) 100 (44.5)
Several days/week 140 (14.0) 102 (13.2) 38 (16.8)
Study area
Taabo-Cite´ 500 (50.1) 364 (47.2) 136 (60.2) 0.003
Amani-Me´nou 244 (24.5) 200 (25.9) 44 (19.5)
Tokohiri 253 (25.4) 207 (26.9) 46 (20.3)
Self-reported fever 142 (14.2) 100 (13.0) 42 (18.6) 0.034
Anaemia 207 (20.8) 151 (19.6) 56 (24.8) 0.090
General susceptibility to illness 436 (43.7) 321 (41.6) 115 (50.9) 0.014
Malaria parasitaemia a 103 (10.1) 86 (11.5) 14 (6.2) 0.029
RDT malaria parasitaemia-positive 96 (9.6) 84 (10.9) 12 (5.3) 0.012
Microscopy malaria parasitaemia-positive 54 (5.4) 46 (5.9) 8 (3.5) 0.156
Malaria medication 55 (5.5) 37 (4.8) 18 (7.9) 0.067
Family history of hypertension 277 (27.8) 192 (24.9) 85 (37.6) <0.001
Missing data, waist circumference 4 (0.4) 3 (0.4) 1 (0.4) 0.911
Missing data, BMI 3 (0.3) 2 (0.3) 1 (0.4) 0.659
Missing data, body temperature 17 (1.7) 12 (1.6) 5 (2.2) 0.503
Continuous variables Mean (SD) Mean (SD) Mean (SD) t-test
Age (years) 42 (13) 40 (13) 51 (12) <0.001
Waist circumference (cm) 81 (11) 79 (10) 86 (13) <0.001
BMI (kg/m2) 23.4 (4.2) 22.9 (3.8) 24.9 (4.8) <0.001
Body temperature (8C) 36.5 (0.5) 36.5 (0.5) 36.5 (0.5) 0.114
SBP (mmHg) 122 (18) 115 (11) 145 (20) <0.001
DBP (mmHg) 79 (12) 75 (7) 94 (13) <0.001
Mean arterial pressure 94 (13) 88 (8) 111 (14) <0.001
Haemoglobin level (g/dl) 13.3 (1.6) 13.4 (1.5) 13.3 (1.6) 0.437
Sedentariness (h/week) 33 (17) 32 (16) 36 (21) 0.001
Plasmodium density (per ml) 558 (1750) 602 (1873) 263 (303) 0.637
Hypertension was defined as SBP at least 140mmHg or DBP at least 90mmHg or clinician-diagnosed hypertension. Anaemia was indirectly measured using Hb level and categorized
according to WHO guidelines [38]. Missing data represents the number of participants who had single imputations of age-adjusted, sex-adjusted and area-adjusted means of the
respective variation. Wealth index was derived from a principal component analysis, including all assets owned by the household of participants. Sedentariness was defined as hours per
week spent in a sitting or lying position, excluding sleeping hours. RDT, rapid diagnostic test.
aPositive malaria rapid diagnostic test or microscopy.
Malaria parasitaemia and hypertensionhypertension in our study. We observed a negative associ-
ation in participants without self-reported fever (OR 0.40;
95% CI 0.17–0.98), and a positive association in those
reporting fever (OR 2.30; 95% CI 0.58–9.21). Similarly,
we observed a negative association in participants with
body temperature 36.5 8C or less (OR 0.23; 95% CI 0.06–Journal of Hypertension0.84) and a positive association in those with body temper-
ature greater than 36.5 8C (OR 1.21; 95% CI 0.50–2.92). This
trend was similar for prehypertension (Fig. 1).
We observed a stronger magnitude of association in the
participants with self-reported fever or having higher body
temperature in models limited to microscopic malariawww.jhypertension.com 1387
TABLE 2. Association between malaria parasitaemia and hypertension phenotypes in the Coˆte d’Ivoire Dual Burden of Disease Study
Normotension Prehypertension Hypertension
Model 441 330 226
N OR (95% CI) OR (95% CI) OR (95% CI)
Model 1: unadjusted Reference 0.81 (0.51–1.29) 0.48 (0.26–0.89)
Model 2: model 1 combined with age and sex Reference 0.85 (0.53–1.36) 0.56 (0.29–1.08)
Model 3: model 2 combined with education, wealth and area Reference 0.88 (0.54–1.41) 0.65 (0.34–1.27)
Model 4: model 3 combined with family history of hypertension Reference 0.88 (0.55–1.41) 0.65 (0.33–1.26)
Model 5: model 4 combined with smoking, fruits and vegetables Reference 0.89 (0.55–1.44) 0.64 (0.33–1.25)
Model 6: model 5 combined with BMI, WC, and sedentariness Reference 0.95 (0.58–1.55) 0.66 (0.33–1.33)
Model 7: model 6 combined with anaemiaa Reference 0.97 (0.59–1.58) 0.65 (0.32–1.33)
Model 7, RDT positive regardless of microscopyb Reference 0.93 (0.57–1.53) 0.55 (0.26–1.15)
Model 7, microscopy positive regardless of RDTc Reference 1.09 (0.57–2.11) 1.05 (0.41–2.67)
Model 7, RDT-only positive (excluding microscopy positive)d Reference 0.81 (0.40–1.64) 0.40 (0.14–1.14)
Model 7, microscopy positive excluding RDT-only positive casese Reference 1.08 (0.56–2.09) 0.99 (0.39–2.51)
All estimates were derived from multinomial logistic regression models comparing odds of prehypertension and hypertension in malaria-positive vs. malaria-negative participants. Age
(years), BMI (kg/m2) and waist circumference (cm) were treated as continuous variables. Education was measured as formal education (yes/no); wealth index was derived from a
principal component analysis, including all assets owned by the household of participants; smoking was categorized as never, former or current; fruit and vegetable intake was
categorized into never/monthly/weekly/several days per week, respectively; waist circumference was measured at the level of the umbilicus at point of expiration; sedentariness was
measured as hours per week spent in a sitting or lying position excluding night-time sleeping hours. Anaemia was indirectly measured using Hb level and categorized according to WHO
guidelines [38]. CI, confidence interval; OR, odds ratio; RDT, rapid diagnostic test.
aN (parasitaemia)¼100.
bN (parasitaemia)¼ 96.
cN (parasitaemia)¼54.
dN (normotension)¼413; N (prehypertension)¼312; N (hypertension)¼218; N (parasitaemia)¼ 46.
eN (normotension)¼416; N (prehypertension)¼315; N (hypertension)¼220; N (parasitaemia)¼54.
Eze et al.parasitaemia. Adjusted ORs of hypertension in relation to
microscopic malaria parasitaemia was 4.89 (95% CI 0.90–
26.90; P¼ 0.07) among those with self-reported fever
(Pinteraction¼ 0.03), and 2.93 (95% CI 0.94–9.14; P¼ 0.06)
among those with body temperature greater than 36.5 8C
(Pinteraction¼ 0.02). We found differences by diagnostic test
(Pinteraction(RDT vs. microscopy)¼ 0.03), in the modifying effect
of body temperature on malaria parasitaemia–hyperten-
sion association. We also found similar test-specific trends
with prehypertension (Table 3).
Combinations of presence of malaria parasitaemia, ele-
vated body temperature and diagnostic test showed posi-
tive associations between being microscopic malaria
parasitaemia-positive and having elevated body tempera-
ture with hypertension [OR 3.37 (95% CI 1.12–10.10)]
compared with being malaria parasitaemia-negative with-
out elevated body temperature. This finding was also
replicated with both SBP and DBP where their sample
mean increased by 8.8mmHg (95% CI 2.9–14.6mmHg)
and 4.1mmHg (95% CI 0.3–7.9mmHg), respectively
(Table 4).
DISCUSSION
We found that the cross-sectional distributions of BP and
malaria parasitaemia were not independent. The associa-
tions depended on latency and symptomaticity of infection,
and did not importantly depend on common hypertension
risk factors. The differences in the direction of association
observed between RDT malaria parasitaemia and micro-
scopic malaria parasitaemia might be because of the long
half-life of P. falciparumHRP-II antigens, which means that
they can still be detected for several days following malaria
treatment [39]. Thus, the RDTs may have picked up the
more latent or asymptomatic cases, in comparison to
microscopy, which may have identified more active malaria1388 www.jhypertension.comcases, thus preferred in practice for monitoring malaria
treatment [37].
Among participants whose malaria parasitaemia was
more likely latent and asymptomatic (RDT-diagnosed; no
signs of elevated temperature), the risk of hypertension
tended to be lower, compared with those with neither
malaria parasitaemia nor elevated body temperature. Per-
sons with this type of malaria parasitaemia have a higher
likelihood of efficiently fighting infections, in particular,
because self-reported low illness susceptibility further
decreased the risk of hypertension. This result is consistent
with a causal effect of malaria parasitaemia on hyperten-
sion, if the currently observed malaria parasitaemia circum-
stances reflect a more general and long-term propensity to
efficiently fight a Plasmodium infection, which is more
prevalent than among those not currently having malaria
parasitaemia. In this case, the lower level of BP among the
participants with more latent malaria may reflect that they
possibly had fewer severe infections and pro-inflammatory
episodes over the life course [7,9,12–14].
This result is also compatible with the shared origin
hypothesis and the relation to selective pressure of genes
protecting against malaria [40]. The observed association of
latent malaria with lower hypertension risk suggests that
genetic variants were selected, which protect humans
against severe malaria and at the same time protect against
high BP. This is also supported by the fact that the protec-
tive effect of latent malaria tended to be stronger with a
positive family history of hypertension.
Candidate genes potentially relevant to the shared origin
hypothesis exist. First, genetic variants of ACE (D allele of
ACE I/D polymorphism), which were associated with
higher ACE levels and increased conversion of angioten-
sin-I to angiotensin-II [28], were associated with hyperten-
sion [41], and milder forms of malaria in Indian population
[28]. This is not in line with our finding of an inverseVolume 37  Number 7  July 2019
FIGURE 1 Adjusted odds ratios (circular points) and 95% confidence intervals (spikes) of the association between malaria parasitaemia (defined as positive microscopy or
rapid diagnostic test) and hypertension phenotypes, stratified by potential modifiers. All estimates were derived from multivariable multinomial logistic regression models
comparing odds of prehypertension and hypertension in malaria-positive vs. malaria-negative participants. All models were adjusted for age, sex, formal education, wealth
index, area, family history of hypertension, smoking, fruit and vegetable intake, BMI, waist circumference, sedentariness and anaemia. Susceptibility was defined as a self-
report of falling ill more frequently than people of the same sex and age group. CI, confidence interval; HTN, hypertension. P value of interaction is 0.05; P value of
interaction is 0.04.
Malaria parasitaemia and hypertensionassociation between latent malaria and hypertension. But in
line with our findings is a recent study from Nigeria where
serum levels of ACE were higher in patients without malaria
than in malaria cases, and ACE level was inversely corre-
lated with malaria severity [29]. Second, genetic variants on
chemokine receptor 1 (CR1) gene, which are related to
atherosclerosis [42] also conferred protection from severe
malaria [43,44].
Among participants with microscopic malaria, accompa-
nied by elevated body temperature, whose infection is
more likely acute and symptomatic, a tendency toward
higher BP was observed compared with those without
malaria parasitaemia and elevated body temperature.Journal of HypertensionSeveral aspects may explain this positive association. First,
elevated BP could be the acute outcome of disease and
fever. Second, the current nonlatent disease could be
representative of the person’s more general reaction to
infection. In this case, the participants may have experi-
enced more severe infections and pro-inflammatory epi-
sodes in the past, mediating the effect on high BP. In-utero
exposure to microscopic malaria was associated with BP in
adolescents [12]. Fever, characteristic of symptomatic
malaria results from inflammation and may lead to haemo-
dynamic changes, which raise BP to improve perfusion and
restore homeostasis [45,46]. Third, the observed positive
association may again reflect shared genetics withwww.jhypertension.com 1389
TABLE 3. Association betweenmalaria parasitaemia (rapid diagnostic test-diagnosed vs. microscopy-diagnosed) and hypertension in the
Coˆte d’Ivoire Dual Burden of Disease Study, all participants and stratified by age, sex, the presence of elevated body
temperature and self-reported susceptibility to illnesses
Malaria diagnosis based on RDT only,
excluding participants with malaria
diagnosis based on microscopya
Malaria diagnosis based on microscopy,
excluding participants with malaria
diagnosis based only on RDTb
Normotension Prehypertension Hypertension Normotension Prehypertension Hypertension
Subgroup OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
All participants Reference 0.81 (0.40–1.64) 0.40 (0.14–1.14) Reference 1.08 (0.56–2.09) 0.99 (0.39–2.51)
Self-reported fever
No Reference 0.73 (0.34–1.57) 0.38 (0.12–1.19) Reference 0.81 (0.39–1.70) 0.41 (0.11–1.61)
Yes Reference 1.61 (0.23–11.4) 0.52 (0.05–5.98) Reference 4.60 (0.96–22.00) 4.89 (0.90–26.90)
P value 0.46 0.82 0.05 0.03
Body temperaturec
36.5 8C or less Reference 0.87 (0.31–2.46) 0.30 (0.05–1.66) Reference 0.81 (0.32–2.03) 0.15 (0.02–1.27)
>36.5 8C Reference 0.72 (0.27–1.92) 0.47 (0.13–1.73) Reference 1.35 (0.53–3.46) 2.93 (0.94–9.14)
P value 0.79 0.68 0.44 0.02
Illness susceptibility
Low Reference 0.57 (0.23–1.39) 0.37 (0.10–1.38) Reference 0.71 (0.31–1.65) 0.60 (0.16–2.23)
High Reference 1.39 (0.43–4.54) 0.50 (0.09–2.82) Reference 2.04 (0.70–5.96) 2.09 (0.54–8.12)
P value 0.24 0.79 0.13 0.20
All estimates were derived from multivariable multinomial logistic regression models comparing odds of prehypertension and hypertension in malaria positive vs. negative participants. All
models were adjusted for age, sex, formal education, wealth index, area, family history of hypertension, smoking, fruits and vegetables, BMI, waist circumference, sedentariness and
anaemia. CI, confidence interval; OR, odds ratio; RDT, rapid diagnostic test. P values represent the significance level of the difference in estimates between comparative groups.
aN (normotension)¼413; N (prehypertension)¼312; N (hypertension)¼218; N (parasitaemia)¼46.
bN (normotension)¼416; N (prehypertension)¼315; N (hypertension)¼220; N (parasitaemia)¼ 54.
cP value of interaction (RDT vs. microscopy) for hypertension is 0.03.
Eze et al.individuals susceptible to severe malaria being at higher
risk of hypertension. The mechanisms behind shared
genetics are still unclear, but the strengthening of the
endothelial–brain barrier via vasoconstriction is thought
to be a pathway to reduce the occurrence of cerebral
malaria, evidenced by experimental mouse models [30].
The strengths of our study include being the first
population-based survey, to our knowledge, investigating
the direct association of malaria parasitaemia and
hypertension. We also investigated associations with pre-
hypertension, a preclinical phenotype of hypertension. Our
composite definition of hypertension using objectively
measured BP as well as self-reported clinician diagnoses
limited outcome misclassification. Likewise, theTABLE 4. Association of hypertension and blood pressurewith combin
temperature in the Coˆte d’Ivoire Dual Burden of Disease Stu
Normotension Prehyperten
N OR (95% CI) OR (95%
Malaria parasitaemia-negative without
elevated body temperature
433 Reference Referenc
Malaria parasitaemia-negative with
elevated body temperature
464 Reference 1.17 (0.83–1
RDT-only malaria parasitaemia-positive,
without elevated body temperature
21 Reference 0.87 (0.31–2
RDT-only malaria parasitaemia-positive,
with elevated body temperature
25 Reference 0.94 (0.35–2
Microscopic malaria parasitaemia-positive,
without elevated body temperature
22 Reference 0.50 (0.17–1
Microscopic malaria parasitaemia-positive,
with elevated body temperature
32 Reference 2.13 (0.88–5
Estimates of prehypertension and hypertension were derived from multivariable multinomial log
linear regression models comparing malaria-positive vs. malaria-negative participants. Parasitaem
temperature implies having self-reported fever or measured body temperature greater than 36.
history of hypertension, smoking, fruit and vegetable intake, BMI, waist circumference, sedenta
group. b, beta-coefficient; CI, confidence interval; OR, odds ratio; RDT, rapid diagnostic test.
aModels additionally exclude 41 participants on antihypertensive medication.
1390 www.jhypertension.comcombination of RDT and microscopy for malaria parasitae-
mia diagnosis improved case detection, and allowed dif-
ferentiating latent from nonlatent malaria as potential proxy
measures for the efficiency of an organism in controlling
infection. The availability of detailed information on risk
factors enabled the control of potential confounding in
our analyses.
Our study is limited by its cross-sectional nature, which
precludes causal inference from our findings. We could,
therefore, not distinguish between malaria parasitaemia
effects on short-term BP elevation from malaria parasitae-
mia effects on risk of developing hypertension. We may
have had some malaria parasitaemia exposure misclassifi-
cation as we did not apply PCR test toward the identificationations ofmalaria parasitaemia, basis ofmalaria diagnosis and body
dy
sion Hypertension SBPa DBPa
CI) OR (95% CI) b (95% CI) b (95% CI)
e Reference Reference Reference
.63) 1.20 (0.80–1.80) 1.89 (0.29 to 4.06) 0.81 (0.6 to 2.22)
.46) 0.30 (0.05–1.65) 3.82 (10.70 to 3.10) 1.95 (6.43 to 2.54)
.49) 0.60 (0.16–2.22) 0.38 (6.78 to 6.01) 2.47 (6.61 to 1.67)
.48) n.a 6.21 (13.00 to 0.59) 6.69 (11.10 to 2.29)
.16) 3.37 (1.12–10.10) 8.78 (2.92–14.60) 4.08 (0.28–7.88)
istic regression models whereas those of SBP and DBP were derived from multivariable
ia-negative implies a negative test to both RDT and microscopy. Elevated body
5 8C. All models were adjusted for age, sex, formal education, wealth index, area, family
riness and anaemia. n.a, not applicable because of lack of hypertension case in the
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Malaria parasitaemia and hypertensionof malaria parasitaemia cases. Although the combination of
both microscopy and RDT has limited this misclassification,
PCR might have identified additional malaria parasitaemia,
and should be applied in future studies to more accurately
capture the malaria parasitaemia profile of the population.
A further limitation of the current and prior studies is the
challenge in measuring the efficiency of human organisms
in containing an infection over the life course. According
immunological or other markers specific to this malaria-
endemic setting do not exist to our knowledge. In addition,
information on exposure to severe malaria infections in
utero or early childhood was not obtainable. Despite our
relatively low study sample, the prevalence of hypertension
in our population corresponds to that (25.6%) of the 2005
subnational survey in Coˆte d’Ivoire [47], and the prevalence
of hypertension in malaria in our study (14%) is also similar
to that (20%) of another study [29].
In conclusion, the results of this study suggest that malaria
and BP may influence each other or share a genetic back-
ground in a complex manner. The immediate implication of
our findings is the recommendation to abstain from diagnos-
ing a new hypertension in the setting of an acute malaria
infection. From a public health perspective, it becomes
obvious that burden of risk estimates for hypertension in
LMICs should consider the dual disease burden. Well
designed and highly powered longitudinal studies, consid-
ering malaria and hypertension phenotypes, are needed to
test and differentiate between the hypothesizedmechanisms
mediating the malaria–hypertension association. Mendelian
randomization approaches, as recently proposed on the
basis of sickle cell trait variants, not associated with hyper-
tension [23], would allow to specifically investigate the
causality of malaria effect on hypertension.
ACKNOWLEDGEMENTS
We thank the CoDuBu field team for their efforts in data
collection. The field team constituted staff from the Taabo
health and demographic surveillance system, Centre Suisse
de Recherches Scientifiques en Coˆte d’Ivoire, Universite´
Fe´lix Houphoue¨t-Boigny, Institut National de Sante´ Pub-
lique and Ligue Ivoirienne contre l’Hypertension Arte´rielle
et les Maladies Cardiovasculaires, Abidjan, Coˆte d’Ivoire.
We thank the people of the Taabo district and the partic-
ipants of this study for their long-term time and trust.
Funding: Unrestricted grant from Novartis Foundation
(Project No. 2015–16).
Conflicts of interest
There are no conflicts of interest.
REFERENCES
1. Guwatudde D, Nankya-Mutyoba J, Kalyesubula R, Laurence C, Ade-
bamowo C, Ajayi I, et al. The burden of hypertension in sub-Saharan
Africa: a four-country cross sectional study. BMC Public Health 2015;
15:1211.
2. Cappuccio FP, Miller MA. Cardiovascular disease and hypertension in
sub-Saharan Africa: burden, risk and interventions. Intern Emerg
Medicine 2016; 11:299–305.
3. Moran A, Forouzanfar M, Sampson U, Chugh S, Feigin V, Mensah G.
The epidemiology of cardiovascular diseases in sub-Saharan Africa: the
Global Burden of Diseases, Injuries and Risk Factors 2010 Study. Prog
Cardiovasc Dis 2013; 56:234–239.Journal of Hypertension4. Koopman JJ, van Bodegom D, Jukema JW, Westendorp RG. Risk of
cardiovascular disease in a traditional African population with a high
infectious load: a population-based study. PLoS One 2012; 7:e46855.
5. Opie LH, Seedat YK. Hypertension in sub-Saharan African populations.
Circulation 2005; 112:3562–3568.
6. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al.
A comparative risk assessment of burden of disease and injury attrib-
utable to 67 risk factors and risk factor clusters in 21 regions, 1990–
2010: a systematic analysis for the Global Burden of Disease Study
2010. Lancet 2012; 380:2224–2260.
7. Etyang AO, Smeeth L, Cruickshank JK, Scott JA. Themalaria-high blood
pressure hypothesis. Circ Res 2016; 119:36–40.
8. Gallego-Delgado J, Walther T, Rodriguez A. The high blood pressure-
malaria protection hypothesis. Circ Res 2016; 119:1071–1075.
9. Moxon CA, Chisala NV, Wassmer SC, Taylor TE, Seydel KB, Molyneux
ME, et al. Persistent endothelial activation and inflammation after
Plasmodium falciparum Infection in Malawian children. J Infect Dis
2014; 209:610–615.
10. Chuang SY, Hsu PF, Chang HY, Bai CH, Yeh WT, Pan HW. C-reactive
protein predicts systolic blood pressure and pulse pressure but not
diastolic blood pressure: the Cardiovascular Disease Risk Factors Two-
Township Study. Am J Hypertens 2013; 26:657–664.
11. Hamer M, Chida Y. Associations of very high C-reactive protein
concentration with psychosocial and cardiovascular risk factors in
an ageing population. Atherosclerosis 2009; 206:599–603.
12. Bedu-Addo G, Alicke M, Boakye-Appiah JK, Abdul-Jalil I, van der Giet
M, Schulze MB, et al. In utero exposure to malaria is associated with
metabolic traits in adolescence: The Agogo 2000 birth cohort study. J
Infect 2017; 75:455–463.
13. Cruickshank JK, Mzayek F, Liu L, Kieltyka L, Sherwin R, Webber LS,
et al. Origins of the ‘black/white’ difference in blood pressure: roles of
birth weight, postnatal growth, early blood pressure, and adolescent
body size: the Bogalusa heart study. Circulation 2005; 111:1932–1937.
14. Law CM, Shiell AW, Newsome CA, Syddall HE, Shinebourne EA, Fayers
PM, et al. Fetal, infant, and childhood growth and adult blood pressure:
a longitudinal study from birth to 22 years of age. Circulation 2002;
105:1088–1092.
15. Ndao CT, Dumont A, Fievet N, Doucoure S, Gaye A, Lehesran JY.
Placental malarial infection as a risk factor for hypertensive disorders
during pregnancy in Africa: a case-control study in an urban area of
Senegal, West Africa. Am J Epidemiol 2009; 170:847–853.
16. Kang H, Kreuels B, Adjei O, Krumkamp R, May J, Small DS. The causal
effect of malaria on stunting: a Mendelian randomization and matching
approach. Int J Epidemiol 2013; 42:1390–1398.
17. Hopstock LA, Barnett AG, Bonaa KH, Mannsverk J, Njolstad I, Wils-
gaard T. Seasonal variation in cardiovascular disease risk factors in a
subarctic population: the Tromso Study 1979–2008. J Epidemiol Com-
munity Health 2013; 67:113–118.
18. Gazzinelli RT, Kalantari P, Fitzgerald KA, Golenbock DT. Innate
sensing of malaria parasites. Nat Rev Immunol 2014; 14:744–757.
19. Asgar Pour H, Yavuz M. Effects of fever on haemodynamic parameters
in neurosurgical intensive care unit patients. Intensive Crit Care Nurs
2014; 30:325–332.
20. Sampson UK, Edwards TL, Jahangir E, Munro H, Wariboko M, Wassef
MG, et al. Factors associatedwith the prevalence of hypertension in the
southeastern United States: insights from 69,211 blacks and whites in
the Southern Community Cohort Study. Circ Cardiovasc Qual Out-
comes 2014; 7:33–54.
21. Gallego-Delgado J, Rodriguez A. Malaria and hypertension. Another
co-evolutionary adaptation? Front Cell Infect Microbiol 2014; 4:121.
22. Kwiatkowski DP. How malaria has affected the human genome and
what human genetics can teach us about malaria. Am J Hum Genet
2005; 77:171–192.
23. Etyang AO, Wandabwa CK, Kapesa S, Muthumbi E, Odipo E, Wamu-
koya M, et al. Blood pressure and arterial stiffness in kenyan adoles-
cents with the sickle cell trait. Am J Epidemiol 2018; 187:199–205.
24. Jain S, Tang X, Narayanan CS, Agarwal Y, Peterson SM, BrownCD, et al.
Angiotensinogen gene polymorphism at -217 affects basal promoter
activity and is associatedwith hypertension in African-Americans. J Biol
Chem 2002; 277:36889–36896.
25. Simonyte S, Kuciene R, Medzioniene J, Dulskiene V, Lesauskaite V.
Renin-angiotensin system gene polymorphisms and high blood pres-
sure in Lithuanian children and adolescents. BMC Med Genet 2017;
18:100.www.jhypertension.com 1391
Eze et al.26. Deo SH, Holwerda SW, Keller DM, Fadel PJ. Elevated peripheral blood
mononuclear cell-derived superoxide production in healthy young
black men. Am J Physiol Heart Circ Physiol 2015; 308:H548–H552.
27. Dluzen DF, Noren Hooten N, Zhang Y, Kim Y, Glover FE, Tajuddin SM,
et al. Racial differences in microRNA and gene expression in hyper-
tensive women. Sci Rep 2016; 6:35815.
28. Dhangadamajhi G, Mohapatra BN, Kar SK, Ranjit M. Gene polymor-
phisms in angiotensin I converting enzyme (ACE I/D) and angiotensin
II converting enzyme (ACE2 C–>T) protect against cerebral malaria in
Indian adults. Infect Genet Evol 2010; 10:337–341.
29. Abdulazeez A, Ya’uM, Kurfi B. Association of hypertension and activity
of angiotensin converting enzyme in malaria patients attending Sheik
Muhammad Jidda General Hospital, Kano State, Nigeria. Nigerian J
Basic Clin Sci 2017; 14:121.
30. Gallego-Delgado J, Baravian C, Edagha I, Ty MC, Ruiz-Ortega M, XuW,
et al. Angiotensin II moderately decreases plasmodium infection and
experimental cerebral malaria in mice. PLoS One 2015; 10:e0138191.
31. Anigbogu C, Olubowale O. Effects of malaria on blood pressure, heart
rate, electrocardiogram and cardiovascular response to change in
posture. Nig Q J Hosp Med 2002; 12:17–20.
32. Bassa FK, Ouattara M, Silue´ KD, Adiossan LG, Baikoro N, Kone´ S, et al.
Epidemiology of malaria in the Taabo health and demographic sur-
veillance system, south-central Coˆte d’Ivoire. Malar J 2016; 15:9.
33. Righetti AA, Adiossan LG, Ouattara M, Glinz D, Hurrell RF, N’Goran EK,
et al. Dynamics of anemia in relation to parasitic infections, micronu-
trient status, and increasing age in South-Central Coˆte d’Ivoire. J Infect
Dis 2013; 207:1604–1615.
34. Kone´ S, Baikoro N, N’Guessan Y, Jaeger FN, Silue´ KD, Furst T, et al.
Health & demographic surveillance system profile: the Taabo Health
and Demographic Surveillance System, Coˆte d’Ivoire. Int J Epidemiol
2015; 44:87–97.
35. Eze IC, Esse C, Bassa FK, Knoe´ S, Acka F, Yao L, et al. Coˆte d’Ivoire Dual
Burden of Disease (CoDuBu): study protocol to investigate the co-
occurrence of chronic infections and noncommunicable diseases in
rural settings of epidemiological transition. JMIR Res Protoc 2017;
6:e210.1392 www.jhypertension.com36. Raso G, Luginbuhl A, Adjoua CA, Tian-Bi NT, Silue´ KD, Matthys B, et al.
Multiple parasite infections and their relationship to self-reported
morbidity in a community of rural Coˆte d’Ivoire. Int J Epidemiol
2004; 33:1092–1102.
37. Abba K, Deeks JJ, Olliaro P, Naing CM, Jackson SM, Takwoingi Y, et al.
Rapid diagnostic tests for diagnosing uncomplicated P. falciparummalaria
in endemic countries. Cochrane Database Syst Rev (7):2011;CD008122.
38. WHO. Haemoglobin concentrations for the diagnosis of anaemia and
assessment of severity. Vitamin and Mineral Nutrition Information
Systems. Geneva: World Health Organization; 2011.
39. Tahar R, Sayang C, Ngane Foumane V, Soula G, Moyou-Somo R,
Delmont J, et al. Field evaluation of rapid diagnostic tests for malaria
in Yaounde, Cameroon. Acta Trop 2013; 125:214–219.
40. Gurdasani D, Carstensen T, Tekola-Ayele F, Pagani L, Tachmazidou I,
Hatzikotoulas K, et al. The African Genome Variation Project shapes
medical genetics in Africa. Nature 2015; 517:327–332.
41. Choudhury I, Jothimalar R, Patra AK. Angiotensin converting enzyme
gene polymorphism and its association with hypertension in South
Indian Population. Indian J Clin Biochem 2012; 27:265–269.
42. Boiocchi C, Zorzetto M, Sbarsi I, Pirotta A, Schirinzi S, Falcone C, et al.
CR1 genotype and haplotype involvement in coronary artery disease:
the pivotal role of hypertension and dyslipidemia. Int J Mol Med 2009;
24:181–187.
43. Panda AK, Panda M, Tripathy R, Pattanaik SS, Ravindran B, Das BK.
Complement receptor 1 variants confer protection from severe malaria
in Odisha, India. PLoS One 2012; 7:e49420.
44. Kosoy R, RansomM, Chen H, Marconi M, Macciardi F, Glorioso N, et al.
Evidence for malaria selection of a CR1 haplotype in Sardinia. Genes
Immun 2011; 12:582–588.
45. Walter EJ, Hanna-Jumma S, Carraretto M, Forni L. The pathophysio-
logical basis and consequences of fever. Crit Care 2016; 20:200.
46. Rodbard S. Body temperature, blood pressure, and hypothalamus.
Science 1948; 108:413–415.
47. WHO. Enqueˆte sur les facteurs de risque des maladies non trans-
missibles. Coˆte d’Ivoire, Regions sanitaire des Lagunes. Geneva: World
Health Organization; 2005.Volume 37  Number 7  July 2019
